Get notified when ORKA files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Concentrated Ownership: Entities Affiliated With Fairmount Funds Management Llc Beneficially Own Approximately 35.2% of Common Stock (new) — A single affiliated group holds over one-third of the company, giving it significant influence over corporate decisions and potential future sales that could depress the stock price.
  • Immediate Dilution of $53.14 Per Share to New Investors (new) — The offering price is substantially above adjusted net tangible book value, causing new investors to absorb a large per-share loss in book value immediately.
  • Large Option and Warrant Overhang With Exercise Prices Well Below the Offer Price (new) — Over 16 million shares are issuable upon exercise of outstanding options and warrants, many with exercise prices far below $72.50, creating significant potential future dilution.
NASDAQ: ORKA Oruka Therapeutics, Inc. 424B5

Oruka Therapeutics prices 9.66M-share IPO at $72.50, raising $658.2M net for R&D and working capital

Filed April 29, 2026 · ~1 min read

Key Changes

  • high

    Oruka is selling 9,660,000 shares at $72.50 per share in a primary offering; gross proceeds are $700.4M before underwriting discounts.

    The Offering verify on EDGAR →
  • high

    Net proceeds to the company are $658.2M after underwriting discounts and estimated expenses; underwriters have a 30-day option for 1,449,000 additional shares.

    Use of Proceeds verify on EDGAR →
  • medium

    The company intends to use net proceeds for general corporate purposes, including research and development and working capital, with broad management discretion.

    Use of Proceeds verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.

Partner

Trade ORKA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify